Bio-Rad Laboratories (BIO) Inventory Average (2010 - 2026)
Bio-Rad Laboratories' (BIO) quarterly Inventory Average came in at $755.6 million in Q1 2026, down 2.51% year-on-year from $775.0 million in Q1 2025, and down 0.83% on a QoQ basis from $761.9 million in Q4 2025.
Bio-Rad Laboratories (BIO) Inventory Average (2010 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has 17 years of Inventory Average data on file, last reported at $755.6 million in Q1 2026.
- On a quarterly basis, Inventory Average fell 2.51% year-over-year to $755.6 million in Q1 2026; TTM through Mar 2026 was $755.6 million, a 2.51% decrease from a year earlier, with the FY2025 full-year figure at $750.4 million, down 2.58% from the prior year.
- Inventory Average for Q1 2026 stood at $755.6 million, down from $761.9 million in the prior quarter.
- Over the last five years, Inventory Average for BIO reached as high as $804.0 million in Q3 2024 and fell as low as $588.9 million in Q1 2022.
- Historically, Inventory Average has averaged $746.4 million across 5 years, with a median of $775.0 million in 2025.
- Across the five-year window, Inventory Average dropped 4.05% in 2022 and rose 25.0% in 2023, its largest moves.
- Year by year, Inventory Average stood at $702.6 million in 2022, then grew by 10.75% to $778.2 million in 2023, then advanced by 0.51% to $782.1 million in 2024, then retreated by 2.58% to $761.9 million in 2025, then retreated by 0.83% to $755.6 million in 2026.
- Per Business Quant data, the three most recent Inventory Average figures were $755.6 million in Q1 2026, $761.9 million in Q4 2025, and $791.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 6.74 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 5.36 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.13 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.03 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.12 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 661.35 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.49 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 2.29 Bn |
| 10 | Bio-Rad Laboratories | 8.53 Bn | 6.97 Bn | 309.40 Mn | 755.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 755.60 Mn |
| Dec 31, 2025 | 761.95 Mn |
| Sep 30, 2025 | 791.00 Mn |
| Jun 30, 2025 | 794.45 Mn |
| Mar 31, 2025 | 775.05 Mn |
| Dec 31, 2024 | 782.14 Mn |
| Sep 30, 2024 | 803.98 Mn |
| Jun 30, 2024 | 793.53 Mn |
| Mar 31, 2024 | 781.93 Mn |
| Dec 31, 2023 | 778.16 Mn |
| Sep 30, 2023 | 776.21 Mn |
| Jun 30, 2023 | 764.75 Mn |
| Mar 31, 2023 | 736.11 Mn |
| Dec 31, 2022 | 702.61 Mn |
| Sep 30, 2022 | 671.52 Mn |
| Jun 30, 2022 | 631.31 Mn |
| Mar 31, 2022 | 588.87 Mn |
| Dec 31, 2021 | 580.58 Mn |
| Sep 30, 2021 | 593.95 Mn |
| Jun 30, 2021 | 602.07 Mn |